Results 171 to 180 of about 141,022 (304)

Latent profile analysis of medication adherence in lower extremity deep venous thrombosis-cross-sectional study. [PDF]

PLoS One
Hu N, Li X, Fu F, Xie L, Qi J, Wu P, Li Y, Li YL.   +7 more
europepmc   +1 more source

Estimated impact of model‐guided venous thromboembolism prophylaxis versus real‐world practice

Journal of Hospital Medicine, EarlyView.
Abstract Background The American Society of Hematology (ASH) recommends assessing venous thromboembolism (VTE) and major bleeding risk to optimize pharmacological VTE prophylaxis for medical inpatients. However, the clinical utility of model‐guided approaches remains unknown.
Benjamin G Mittman, Michael B. Rothberg
wiley   +1 more source

Correlation analysis of the systemic immune-inflammation index with preoperative lower extremity deep venous thrombosis in patients with tibial fractures. [PDF]

J Orthop Surg Res
Yang A, Feng Y, Ma X, Xie L, Zhao H, Guan X, Guo H, Ren T.   +7 more
europepmc   +1 more source

Incidence, contributing factors, and predictors of diagnostic errors in medical inpatients: A retrospective cohort study

Journal of Hospital Medicine, EarlyView.
Abstract Background Diagnostic error is a major patient safety concern in hospitals, yet most studies have focused on selected high‐risk subgroups, leaving the broader general internal medicine inpatient population understudied. Objectives To determine the incidence, contributing factors, resulting harm, and predictors of diagnostic error in medical ...
Caterina E. Marx, Elena Hofmann, Martin Perrig, Gurpreet Dhaliwal, Wolf Hautz, Jörg P. Isenegger, Ernst Lipp, Drahomir Aujesky, Manuel R. Blum, Tobias Tritschler   +9 more
wiley   +1 more source

Symptomatic Deep Venous Thrombosis of the Upper Extremity Following Transvenous Lead Extraction, Data From EXTRACT Registry. [PDF]

J Cardiovasc Electrophysiol
Joniec M, Stachanczyk J, Gladysz-Wanha S, Pilat E, Drzewiecka A, Biernat J, Weglarzy A, Wanha W, Gardas R, Golba KS.   +9 more
europepmc   +1 more source

Things We Do for No Reason™: Prescribing gabapentinoids for pain

Journal of Hospital Medicine, EarlyView.
Abstract Gabapentin and pregabalin are among the most frequently prescribed medications in the United States, with gabapentin in the top 10 and pregabalin in the top 100. Despite FDA approval for only select neuropathic conditions, most use is for off‐label pain indications.
Niti G. Patel, David Goese, Steven M. Belknap, Charles L. Madeira, Jeffrey H. Barsuk   +4 more
wiley   +1 more source

An unusual variant of May-Thurner syndrome leading to deep venous thrombosis: a case report. [PDF]

AME Case Rep
Mulayamkuzhiyil J, Joseph J, Ahmad Z, London J, James SA, Mehta P, Gkotsis G.   +6 more
europepmc   +1 more source

Outcomes and adverse effects of teduglutide treatment with periodic withdrawal in pediatric short bowel patients

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives We evaluated the efficacy and safety of teduglutide in a real‐world cohort in which national reimbursement policies required treatment interruptions. The primary outcomes were reduction in parenteral support (PS) and treatment‐related adverse effects, and the secondary outcome was the impact of the mandated withdrawal periods ...
Riikka Gunnar, Annika Mutanen, Mikko P. Pakarinen, Laura Merras‐Salmio   +3 more
wiley   +1 more source

Peripheral thrombus extension is associated with increased risk of recurrent deep venous thrombosis in patients undergoing percutaneous thrombectomy for iliofemoral deep venous thrombosis. [PDF]

J Vasc Surg Venous Lymphat Disord
McGevna MA, Ratner M, Rockman CB, Maldonado TS, Harish KB, Hingorani A, Jacobowitz GR, Sadek M, Berland T, Garg K.   +9 more
europepmc   +1 more source

Successful treatment of eosinophilic esophagitis with upadacitinib prescribed for atopic dermatitis

JPGN Reports, EarlyView.
Abstract We describe a pediatric patient treated with upadacitinib for atopic dermatitis (AD) who subsequently achieved sustained clinical and histologic remission of eosinophilic esophagitis (EoE). Upadacitinib is an oral small molecule selective Janus kinase 1 inhibitor that inhibits janus kinase‐signal transduction and activation of transcription ...
Nathalie Nguyen, Maureen Bauer
wiley   +1 more source